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OL-072 Process development of an affordable bivalent
conjugate vaccine against the two major
causes of enteric fever, Salmonella typhi and
Salmonella paratyphi A
S. Kothari1 *, J.-A. Kim1, R. Carbis1. 1International Vaccine
Institute, Seoul, South Korea
Background: A recent IVI study in Kolkata, India, found that
24% of enteric fever episodes were due to S. paratyphi A.
Estimates indicate that the incidence of enteric fever, in
India, due to S. paratyphi A is 2.2 million cases per annum.
Vi based vaccines only protect against typhoid fever, thus
there is a need for a bivalent vaccine that protects against
both S. typhi and S. paratyphi A.
Methods: IVI transferred its high yield, high recovery
technology for Vi and Vi conjugate production to Shantha
Biotechnics in 2009.
A high yielding fed batch fermentation system for
Salmonella paratyphi A was ﬁrst developed. The
Lipopolysaccharide was separated from the cells using micro
and ultraﬁltration then detoxiﬁed by acid hydrolysis to
release O speciﬁc polysaccharide (OSP) from the Lipid A. The
OSP was further puriﬁed by precipitation of contaminating
Lipid A, proteins and nucleic acid, concentrated by
ultraﬁltration then sterilized by 0.2mm ﬁltration. The
process developed uses equipment that is scalable and
cGMP compliant thus it is anticipated that the technology
transfer and scale up to a manufacturer will not be overly
complicated.
Results: OSP from S. paratyphi A has been successfully
puriﬁed and the ﬁnal bulk contains less than 1% of
contaminating nucleic acid and protein, and very low
endotoxin (by LAL) values. The puriﬁed OSP has been used
to prepare a series of conjugates using Diphtheria Toxoid
(DT) as the carrier protein. The conjugates are currently
undergoing preclinical evaluation.
Conclusion: We have developed a high yielding and efﬁcient
technologies for Vi and OSP production and for conjugation
to these polysaccharides to DT. Our aim is to develop a
cost effective bivalent conjugate vaccine for developing
countries.
This work was funded by the governments of Korea and
Sweden.
OL-073 Evaluation of serum concentration of
endothelium nitric oxide synthase in
Helicobacter pylori positive people
M. Amani1 *, G.H. Ettehad1, F. Afshar1. 1Faculty of
Medicine, Ardabil University of Medical Science, Ardabil,
Iran
Objectives: Endothelium nitric oxide synthase (eNOS) is a
type of enzyme which produces a endogenous factor called
nitric oxide. NO plays important role in progress of euplastic
diseases. In chronic gastritis induced by Helicobacter pylori,
the production of NO enhances and damages DNA. The aim
of present study is to evaluate eNOS concentration in serum
of healthy people and those infected by HP.
Methods: The serums and stools of 84 voluntaries were
collected which %58.3 of them were women. HP antigen
in stool samples and serum concentration of eNOS were
determined using proper ELISA kits. Obtained data were
analyzed using Excell software.
Results: 16.6%, 29.76% and 53.57% of collected samples
were equivocal, HP negative and positive respectively.
Comparison of serums concentration of eNOS showed that
there is no signiﬁcant change among these three groups.
Discussion: As mentioned in results the eNOS serums
concentration shows no signiﬁcant change in HP positive
and negative groups. Albeit the other studies showed the
signiﬁcant increase in serum concentration of HP positive
patient, this contradiction may arise from race and HP
pathogenic slands such as VacA and CagA differences. We
propose to conduct a similar study in Ardabil with special
regard to pathogenic islands.
OL-074 Prevalence of Helicobacter pylori infection
and occurrence of gastric cancer in Northeast
China
X.Y. Cao1, J. Jiang2 *, Z.-F. Jia2, Y. Li2, M.-S. Jin3.
1Department of Gastrointestinal Surgery, First Hospital of
Jilin University, China, 2Division of Clinical Epidemiology,
First Hospital of Jilin University, China, 3Division of
Pathology, First Hospital of Jilin University, China
Background: Although the incidence of stomach
adenocarcinoma has declined in the industrialized world,
gastric cancer is still one of the major malignant tumors
in Northeast China. The aim of this study was to explore
the distribution of Helicobacter pylori (H. pylori) infection
and atrophic gastritis in heath controls and gastric cancer
patients and their role in gastric carcinogenesis in Northeast
China.
Methods: A total of 1072 healthy controls attending
the physical examination center and 416 histologically
conﬁrmed gastric cancer patients hospitalizing for surgical
operation at JiLin University, from August 2008 to December
2010, were included in this study. The IgG antibody titers
of H. pylori and levels of pepsinogen I (PGI) and II (PGII) in
serum of the subjects were measured using ELISA kits.
Result: The rate of positive H. pylori IgG antibody titers
was signiﬁcantly higher in gastric cancer groups than that
in healthy control groups. (70.7% verse 52.4%, P < 0.0001)
The atrophic gastritis was more likely to be diagnosed
in gastric cancer groups than those in the control groups
(32.0% verse 10.4%, P < 0.001). More subjects with H. pylori
infection had lower ratio of PGI and PGII (ratio6.05; 39.4%
verse 4.5%, P < 0.0001) and atrophic gastritis (15.0% verse
5.3%, P < 0.001) than those without H. pylori infection in
the control groups. In addition to H. pylori infection and
atrophic gastritis, multivariate logistic analysis suggested
that male gender, elder age were also associated with
gastric cancer.
Conclusion: Our results indicating that the higher
prevalence of H. pylori infection in gastric cancer patients
in Northeast China. H. pylori infection is a much stronger
risk factor for stomach adenocarcinoma. The study also
conﬁrmed that H. pylori infection were associated with
atrophic gastritis, both H. pylori infection and atrophic
gastritis were linked to the risk for gastric carcinogenesis.
This work was supported by NSFC (No.81072369).
OL-075 Rotavirus infection in Mongolian children
G. Saranguo1, S. Gantuya1, D. Gerelmaa1, G. Oyunchimig2,
Y. Dahgwahdorj1 *. 1Health Sciences University of Mongolia,
2Sukhbaatar district Hospital, Ulaanbaatar, Mongolia
Introduction: Rotavirus infection (RV) wide spread in
Mongolia as other’s world. But, in Mongolia not conducted
any study on rotavirus infection.
Objective: To study the incidence clinical picture and
molecular feature of RV infection in Mongolia.
Method and Patients: We were observed 950 children under
5 years old (male 559), who was randomly selected patients
with acute gastroenteritis from Sukhbaatar district’s
Hospital in Ulaanbaatar from April 2009 to July 2010. In
stool of all studied children detected antigen of RV (RV-Ag)
by ELISA (DAKO). In positive samples detected genotype of
RV by RT-PCR.
